Asia-Pacific Metabolic Disorders Drugs Market Report 2018

June 2018 | 118 pages | ID: A65A44C158EEN
QYResearch

Abstracts

In this report, the Asia-Pacific Metabolic Disorders Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Metabolic Disorders Drugs for these regions, from 2013 to 2025 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Metabolic Disorders Drugs market competition by top manufacturers/players, with Metabolic Disorders Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Zealand Pharma
• Rhythm
• OxThera
• Biophytis
• Biophytis
• Zafgen
• PerkinElmer
• Eternygen
• Pronutria Biosciences
• MedGenome
• CellCentric
• Nimbus Therapeutics
• Mitobridge
• Exelixis, Inc.
• Outpost Medicine
• Anchor Therapeutics
• Verva Pharmaceuticals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Tablet
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Diabetes
• Disorders of the Thyroid and Pituitary Gland
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Metabolic Disorders Drugs Market Report 2018

1 METABOLIC DISORDERS DRUGS OVERVIEW

1.1 Product Overview and Scope of Metabolic Disorders Drugs
1.2 Classification of Metabolic Disorders Drugs by Product Category
  1.2.1 Asia-Pacific Metabolic Disorders Drugs Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Metabolic Disorders Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Tablet
  1.2.4 Injection
1.3 Asia-Pacific Metabolic Disorders Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Metabolic Disorders Drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Diabetes
  1.3.3 Disorders of the Thyroid and Pituitary Gland
  1.3.4 Other
1.4 Asia-Pacific Metabolic Disorders Drugs Market by Region
  1.4.1 Asia-Pacific Metabolic Disorders Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Metabolic Disorders Drugs (2013-2025)
  1.5.1 Asia-Pacific Metabolic Disorders Drugs Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC METABOLIC DISORDERS DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Metabolic Disorders Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Metabolic Disorders Drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Metabolic Disorders Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Metabolic Disorders Drugs Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Metabolic Disorders Drugs (Volume) by Application
2.4 Asia-Pacific Metabolic Disorders Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Metabolic Disorders Drugs Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Market Share by Region (2013-2018)

3 CHINA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Metabolic Disorders Drugs Sales and Value (2013-2018)
  3.1.1 China Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  3.1.3 China Metabolic Disorders Drugs Sales Price Trend (2013-2018)
3.2 China Metabolic Disorders Drugs Sales Volume and Market Share by Type
3.3 China Metabolic Disorders Drugs Sales Volume and Market Share by Application

4 JAPAN METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Metabolic Disorders Drugs Sales and Value (2013-2018)
  4.1.1 Japan Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Metabolic Disorders Drugs Sales Price Trend (2013-2018)
4.2 Japan Metabolic Disorders Drugs Sales Volume and Market Share by Type
4.3 Japan Metabolic Disorders Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Metabolic Disorders Drugs Sales and Value (2013-2018)
  5.1.1 South Korea Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Metabolic Disorders Drugs Sales Price Trend (2013-2018)
5.2 South Korea Metabolic Disorders Drugs Sales Volume and Market Share by Type
5.3 South Korea Metabolic Disorders Drugs Sales Volume and Market Share by Application

6 TAIWAN METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Metabolic Disorders Drugs Sales and Value (2013-2018)
  6.1.1 Taiwan Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Metabolic Disorders Drugs Sales Price Trend (2013-2018)
6.2 Taiwan Metabolic Disorders Drugs Sales Volume and Market Share by Type
6.3 Taiwan Metabolic Disorders Drugs Sales Volume and Market Share by Application

7 INDIA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Metabolic Disorders Drugs Sales and Value (2013-2018)
  7.1.1 India Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  7.1.3 India Metabolic Disorders Drugs Sales Price Trend (2013-2018)
7.2 India Metabolic Disorders Drugs Sales Volume and Market Share by Type
7.3 India Metabolic Disorders Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Metabolic Disorders Drugs Sales and Value (2013-2018)
  8.1.1 Southeast Asia Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Metabolic Disorders Drugs Sales Price Trend (2013-2018)
8.2 Southeast Asia Metabolic Disorders Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Metabolic Disorders Drugs Sales Volume and Market Share by Application

9 AUSTRALIA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Metabolic Disorders Drugs Sales and Value (2013-2018)
  9.1.1 Australia Metabolic Disorders Drugs Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Metabolic Disorders Drugs Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Metabolic Disorders Drugs Sales Price Trend (2013-2018)
9.2 Australia Metabolic Disorders Drugs Sales Volume and Market Share by Type
9.3 Australia Metabolic Disorders Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC METABOLIC DISORDERS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Zealand Pharma
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Zealand Pharma Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Rhythm
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Rhythm Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 OxThera
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 OxThera Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Biophytis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Biophytis
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Zafgen
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Zafgen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 PerkinElmer
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 PerkinElmer Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Eternygen
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Eternygen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Pronutria Biosciences
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Pronutria Biosciences Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 MedGenome
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Metabolic Disorders Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 MedGenome Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 CellCentric
10.12 Nimbus Therapeutics
10.13 Mitobridge
10.14 Exelixis, Inc.
10.15 Outpost Medicine
10.16 Anchor Therapeutics
10.17 Verva Pharmaceuticals

11 METABOLIC DISORDERS DRUGS MANUFACTURING COST ANALYSIS

11.1 Metabolic Disorders Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Metabolic Disorders Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Metabolic Disorders Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Metabolic Disorders Drugs Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC METABOLIC DISORDERS DRUGS MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Metabolic Disorders Drugs Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Metabolic Disorders Drugs Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Metabolic Disorders Drugs Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Metabolic Disorders Drugs Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Metabolic Disorders Drugs Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Metabolic Disorders Drugs Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Metabolic Disorders Drugs Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Metabolic Disorders Drugs Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Metabolic Disorders Drugs Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metabolic Disorders Drugs
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Tablet Product Picture
Figure Injection Product Picture
Figure Asia-Pacific Metabolic Disorders Drugs Sales (K Units) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Metabolic Disorders Drugs by Application in 2017
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Disorders of the Thyroid and Pituitary Gland Examples
Table Key Downstream Customer in Disorders of the Thyroid and Pituitary Gland
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Metabolic Disorders Drugs Market Size (Million USD) by Region (2013-2025)
Figure China Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Market Major Players Product Sales Volume (K Units)(2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Metabolic Disorders Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Metabolic Disorders Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Metabolic Disorders Drugs Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Metabolic Disorders Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Metabolic Disorders Drugs Revenue Share by Players
Table Asia-Pacific Metabolic Disorders Drugs Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Metabolic Disorders Drugs by Type (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Metabolic Disorders Drugs by Type (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Metabolic Disorders Drugs by Region (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Market Share by Region in 2017
Table Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Metabolic Disorders Drugs by Region (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue Market Share by Region in 2017
Table Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Asia-Pacific Metabolic Disorders Drugs Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Market Share by Application (2013-2018)
Figure China Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure China Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table China Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table China Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure China Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table China Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table China Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure China Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure Japan Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table Japan Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure Japan Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table Japan Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table Japan Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure Japan Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure South Korea Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure South Korea Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table South Korea Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table South Korea Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure South Korea Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table South Korea Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table South Korea Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure South Korea Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure Taiwan Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Taiwan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Taiwan Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table Taiwan Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table Taiwan Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table Taiwan Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure India Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table India Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table India Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure India Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table India Metabolic Disorders Drugs Sales Volume (K Units) by Application (2013-2018)
Table India Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure India Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure Southeast Asia Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table Southeast Asia Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Figure Australia Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Australia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Metabolic Disorders Drugs Sales Price (USD/Unit) Trend (2013-2018)
Table Australia Metabolic Disorders Drugs Sales Volume (K Units) by Type (2013-2018)
Table Australia Metabolic Disorders Drugs Sales Volume Market Share by Type (2013-2018)
Figure Australia Metabolic Disorders Drugs Sales Volume Market Share by Type in 2017
Table Australia Metabolic Disorders Drugs Sales Volume (K Units) by Applications (2013-2018)
Table Australia Metabolic Disorders Drugs Sales Volume Market Share by Application (2013-2018)
Figure Australia Metabolic Disorders Drugs Sales Volume Market Share by Application in 2017
Table Zealand Pharma Metabolic Disorders Drugs Basic Information List
Table Zealand Pharma Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Zealand Pharma Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Zealand Pharma Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Zealand Pharma Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Rhythm Metabolic Disorders Drugs Basic Information List
Table Rhythm Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Rhythm Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Rhythm Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Rhythm Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table OxThera Metabolic Disorders Drugs Basic Information List
Table OxThera Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure OxThera Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure OxThera Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure OxThera Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Biophytis Metabolic Disorders Drugs Basic Information List
Table Biophytis Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Biophytis Metabolic Disorders Drugs Basic Information List
Table Biophytis Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Biophytis Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Zafgen Metabolic Disorders Drugs Basic Information List
Table Zafgen Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Zafgen Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Zafgen Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Zafgen Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table PerkinElmer Metabolic Disorders Drugs Basic Information List
Table PerkinElmer Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure PerkinElmer Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure PerkinElmer Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure PerkinElmer Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Eternygen Metabolic Disorders Drugs Basic Information List
Table Eternygen Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eternygen Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Eternygen Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Eternygen Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table Pronutria Biosciences Metabolic Disorders Drugs Basic Information List
Table Pronutria Biosciences Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure Pronutria Biosciences Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table MedGenome Metabolic Disorders Drugs Basic Information List
Table MedGenome Metabolic Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MedGenome Metabolic Disorders Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure MedGenome Metabolic Disorders Drugs Sales Market Share in Asia-Pacific (2013-2018)
Figure MedGenome Metabolic Disorders Drugs Revenue Market Share in Asia-Pacific (2013-2018)
Table CellCentric Metabolic Disorders Drugs Basic Information List
Table Nimbus Therapeutics Metabolic Disorders Drugs Basic Information List
Table Mitobridge Metabolic Disorders Drugs Basic Information List
Table Exelixis, Inc. Metabolic Disorders Drugs Basic Information List
Table Outpost Medicine Metabolic Disorders Drugs Basic Information List
Table Anchor Therapeutics Metabolic Disorders Drugs Basic Information List
Table Verva Pharmaceuticals Metabolic Disorders Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolic Disorders Drugs
Figure Manufacturing Process Analysis of Metabolic Disorders Drugs
Figure Metabolic Disorders Drugs Industrial Chain Analysis
Table Raw Materials Sources of Metabolic Disorders Drugs Major Manufacturers in 2017
Table Major Buyers of Metabolic Disorders Drugs
Table Distributors/Traders List
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table Asia-Pacific Metabolic Disorders Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue Market Share Forecast by Region in 2025
Figure China Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure China Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure South Korea Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Taiwan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Metabolic Disorders Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Australia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Metabolic Disorders Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Metabolic Disorders Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Metabolic Disorders Drugs Price (USD/Unit) Forecast by Type (2018-2025)
Table Asia-Pacific Metabolic Disorders Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure Asia-Pacific Metabolic Disorders Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources